EXACT SCIENCES CORP Costs and Expenses
EXACT SCIENCES CORP reported Costs and Expenses of $751.16 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2024-11-05
- EXACT SCIENCES CORP costs and expenses for the quarter ending 2024-09-30 was $751.16M, a 8.31% increase year-over-year.
- EXACT SCIENCES CORP costs and expenses for the quarter ending 2024-06-30 was $729.32M, a 4.33% increase year-over-year.
- EXACT SCIENCES CORP costs and expenses for the quarter ending 2024-03-31 was $743.95M, a 9.48% increase year-over-year.
- EXACT SCIENCES CORP costs and expenses for the quarter ending 2023-12-31 was $721.13M, a 7.33% increase year-over-year.
- EXACT SCIENCES CORP costs and expenses for fiscal 2023 was $2.79B, a 4.83% increase from fiscal 2022.
- EXACT SCIENCES CORP costs and expenses for fiscal 2022 was $2.66B, a 1.59% increase from fiscal 2021.
- EXACT SCIENCES CORP costs and expenses for fiscal 2021 was $2.62B, a 14.89% increase from fiscal 2020.
- EXACT SCIENCES CORP costs and expenses for fiscal 2020 was $2.28B, a 105.64% increase from fiscal 2019.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | $751.16M 10-Q · filed 2024-11-05 | $1.48B derived: sum of 2 quarters · filed 2024-11-05 | $2.22B 10-Q · filed 2024-11-05 | $2.95B derived: sum of 4 quarters · filed 2024-11-05 | |
| 2024-06-30 | $729.32M 10-Q · filed 2024-07-31 | $1.47B 10-Q · filed 2024-07-31 | $2.19B derived: sum of 3 quarters · filed 2024-07-31 | $2.89B derived: sum of 4 quarters · filed 2024-11-05 | |
| 2024-03-31 | $743.95M 10-Q · filed 2024-05-08 | $1.47B derived: sum of 2 quarters · filed 2024-05-08 | $2.16B derived: sum of 3 quarters · filed 2024-11-05 | $2.86B derived: sum of 4 quarters · filed 2024-11-05 | |
| 2023-12-31 | $721.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $1.41B derived: sum of 2 quarters · filed 2024-11-05 | $2.11B derived: sum of 3 quarters · filed 2024-11-05 | $2.79B 10-K · filed 2024-02-21 | |
| 2023-09-30 | $693.52M 10-Q · filed 2024-11-05 | $1.39B derived: sum of 2 quarters · filed 2024-11-05 | $2.07B 10-Q · filed 2024-11-05 | $2.74B derived: sum of 4 quarters · filed 2024-11-05 | |
| 2023-06-30 | $699.02M 10-Q · filed 2024-07-31 | $1.38B 10-Q · filed 2024-07-31 | $2.05B derived: sum of 3 quarters · filed 2024-07-31 | $2.70B derived: sum of 4 quarters · filed 2024-07-31 | |
| 2023-03-31 | $679.54M 10-Q · filed 2024-05-08 | $1.35B derived: sum of 2 quarters · filed 2024-05-08 | $2.00B derived: sum of 3 quarters · filed 2024-05-08 | $2.68B derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $671.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $1.32B derived: sum of 2 quarters · filed 2024-02-21 | $2.00B derived: sum of 3 quarters · filed 2024-02-21 | $2.66B 10-K · filed 2024-02-21 | |
| 2022-09-30 | $647.89M 10-Q · filed 2023-11-01 | $1.33B derived: sum of 2 quarters · filed 2023-11-01 | $1.99B 10-Q · filed 2023-11-01 | $2.69B derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | $681.22M 10-Q · filed 2023-08-01 | $1.34B 10-Q · filed 2023-08-01 | $2.04B derived: sum of 3 quarters · filed 2024-02-21 | $2.66B derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-03-31 | $663.56M 10-Q · filed 2023-05-09 | $1.36B derived: sum of 2 quarters · filed 2024-02-21 | $1.98B derived: sum of 3 quarters · filed 2024-02-21 | $2.58B derived: sum of 4 quarters · filed 2024-02-21 | |
| 2021-12-31 | $695.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $1.31B derived: sum of 2 quarters · filed 2024-02-21 | $1.92B derived: sum of 3 quarters · filed 2024-02-21 | $2.62B 10-K · filed 2024-02-21 | |
| 2021-09-30 | $618.40M 10-Q · filed 2022-11-03 | $1.22B derived: sum of 2 quarters · filed 2022-11-03 | $1.93B 10-Q · filed 2022-11-03 | $2.81B derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-06-30 | $606.48M 10-Q · filed 2022-08-02 | $1.31B 10-Q · filed 2022-08-02 | $2.19B derived: sum of 3 quarters · filed 2023-02-21 | $2.80B derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-03-31 | $702.62M 10-Q · filed 2022-04-26 | $1.58B derived: sum of 2 quarters · filed 2023-02-21 | $2.20B derived: sum of 3 quarters · filed 2023-02-21 | $2.56B derived: sum of 4 quarters · filed 2023-02-21 | |
| 2020-12-31 | $881.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $1.49B derived: sum of 2 quarters · filed 2023-02-21 | $1.85B derived: sum of 3 quarters · filed 2023-02-21 | $2.28B 10-K · filed 2023-02-21 | $2.28B 10-K · filed 2021-02-16 |
| 2020-09-30 | $611.70M 10-Q · filed 2021-11-02 | $971.24M derived: sum of 2 quarters · filed 2021-11-02 | $1.40B 10-Q · filed 2021-11-02 | $1.79B derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-06-30 | $359.54M 10-Q · filed 2021-07-28 | $789.74M 10-Q · filed 2021-07-28 | $1.18B derived: sum of 3 quarters · filed 2022-02-22 | $1.44B derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-03-31 | $430.19M 10-Q · filed 2021-05-04 | $821.85M derived: sum of 2 quarters · filed 2022-02-22 | $1.08B derived: sum of 3 quarters · filed 2022-02-22 | $1.31B derived: sum of 4 quarters · filed 2022-02-22 | |
| 2019-12-31 | $391.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $646.19M derived: sum of 2 quarters · filed 2022-02-22 | $879.96M derived: sum of 3 quarters · filed 2022-02-22 | $1.11B 10-K · filed 2022-02-22 | |
| 2019-09-30 | $254.53M 10-Q · filed 2020-10-27 | $488.30M derived: sum of 2 quarters · filed 2020-10-27 | $718.42M 10-Q · filed 2020-10-27 | ||
| 2019-06-30 | $233.77M 10-Q · filed 2020-07-31 | $463.89M 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | $230.12M 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | $613.93M 10-K · filed 2021-02-16 | ||||
| 2017-12-31 | $384.30M 10-K · filed 2020-02-21 |